Literature DB >> 6173387

Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus.

J A Cooper, T Hunter.   

Abstract

We have derived a line of A431 human tumor cells infected with Rous sarcoma virus (RSV). The infected cells contain the RSV-transforming protein, pp60src, which has characteristic tyrosine specific protein kinase activity. As in other RSV-transformed cells, a 36,000-dalton protein is phosphorylated in RSV-infected A431 cells. Addition of epidermal growth factor (EGF) to the cells induces further phosphorylation of this protein. In contrast, this phosphoprotein is not detected in uninfected A431 cells, except when treated with EGF. Increased phosphorylation of the EGF receptor protein and of an 81,000-dalton cellular protein is dependent upon addition of EGF to the culture fluids, in both control and RSV-infected A431 cells. The results are discussed with reference to the similarities and differences between the tyrosine-specific protein kinases induced by RSV and activated by EGF.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6173387      PMCID: PMC2112805          DOI: 10.1083/jcb.91.3.878

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  Growth factors produced by sarcoma virus-transformed cells.

Authors:  G J Todaro; J E De Larco
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

2.  Synthesis of avian RNA tumor virus structural proteins.

Authors:  R Eisenman; V M Vogt; H Diggelmann
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Rapid isolation of plasma membranes in high yield from cultured fibroblasts.

Authors:  D Thom; A J Powell; C W Lloyd; D A Rees
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

4.  Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro.

Authors:  G Carpenter; L King; S Cohen
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

5.  Two dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines.

Authors:  J I Garrels
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

6.  Characterization of a normal avian cell protein related to the avian sarcoma virus transforming gene product.

Authors:  M S Collett; J S Brugge; R L Erikson
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

7.  Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts.

Authors:  G Carpenter; K J Lembach; M M Morrison; S Cohen
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

8.  Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor.

Authors:  G Carpenter; L King; S Cohen
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

9.  Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.

Authors:  H Haigler; J F Ash; S J Singer; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

10.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

View more
  24 in total

1.  In vivo effect of sodium orthovanadate on pp60c-src kinase.

Authors:  J W Ryder; J A Gordon
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

2.  Protein phosphorylation in a tetradecanoyl phorbol acetate-nonproliferative variant of 3T3 cells.

Authors:  R Bishop; R Martinez; M J Weber; P J Blackshear; S Beatty; R Lim; H R Herschman
Journal:  Mol Cell Biol       Date:  1985-09       Impact factor: 4.272

3.  Epidermal growth factor (urogastrone)-mediated phosphorylation of a 35-kDa substrate in human placental membranes: relationship to the beta subunit of the guanine nucleotide regulatory complex.

Authors:  K A Valentine-Braun; J K Northup; M D Hollenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

4.  Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids.

Authors:  C M Isacke; R A Lindberg; T Hunter
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

5.  Modulation of p36 phosphorylation in human cells: studies using anti-p36 monoclonal antibodies.

Authors:  C M Isacke; I S Trowbridge; T Hunter
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

Review 6.  Onc genes and other new targets for cancer chemotherapy.

Authors:  H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 7.  Molecular lesions in cancer.

Authors:  H Busch
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  Subcellular location of an abundant substrate (p36) for tyrosine-specific protein kinases.

Authors:  S Courtneidge; R Ralston; K Alitalo; J M Bishop
Journal:  Mol Cell Biol       Date:  1983-03       Impact factor: 4.272

9.  Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF.

Authors:  J E Buss; J E Kudlow; C S Lazar; G N Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

10.  Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.

Authors:  B Friedman; A R Frackelton; A H Ross; J M Connors; H Fujiki; T Sugimura; M R Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.